The present invention is directed to method of preventing or treating neural disease such as Alzheimer’s disease or inhibiting accumulation of β-amy-loid plaques in a subject by administering an effective dosage to the subject an agent (berberine) which inhibits the accumulation of β-amy-loid plaque.....
[Detail]
Use of dihydromyricetin (DMY) as an NF-κB inhibitor or an IKK-β inhibitor for the treatment of arthritis, cancer, autoimmune conditions and other disease is provided. A pharmaceutical composition comprising DMY is also provided.
[Detail]
This invention relates to a new aqueous diphase solvent system for preparing high-purity polysaccharides.
[Detail]
The present invention relates to methods and an apparatus for developing, analyzing, investigating, supporting and advising healthcare and well-being related decisions.
[Detail]
This invention relates to a chemical entity isolated from natural sources for its therapeutic uses. More particularly, it relates to compound that is naturally occurring in the plant of Garcinia yunnanensis Hu and its biological activity of antitumor effects.
[Detail]
| |< <- | [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] | -> >| |
